HK Stock Market Move | EVEREST MED (01952) surged over 9%. The volume increase of Naifukang drives significant performance growth. The mRNA tumor vaccine sector has entered the realization phase.
Cloud Top New Materials (01952) rose over 9% again, as of the time of publication, up 9.13% to HKD 33.94, with a transaction volume of HKD 438 million.
EVEREST MED (01952) rose over 9% again, currently up 9.13%, trading at HKD 33.94, with a transaction volume of HKD 438 million.
In terms of news, EVEREST MED disclosed its interim performance, reporting a revenue of RMB 1.148 billion for the first half of the year, a year-on-year increase of 157%; the adjusted profit was RMB 97 million, turning from a loss to a profit. During the reporting period, the company's commercialization efforts continued to release growth potential. The sales revenue of its core product, Naisukang, reached RMB 889 million, with a year-on-year pure sales increase of 94%, while the coverage in hospitals and the scale of patients continued to expand.
Soochow noted that Merck/Moderna's mRNA tumor vaccine achieved its first success in Phase III, marking the transition from concept to realization. China Securities Co., Ltd. stated that EVEREST MED possesses an end-to-end mRNA technology platform, with AI algorithms creating core competitiveness, laying out personalized tumor vaccine EVM16 and spot vaccine EVM14.
Related Articles
HK Stock Market Move | CR BLDG MAT TEC (01313) fell nearly 3% in the morning session, with the performance for the first half of the year turning from profit to loss compared to the same period last year, and sales of cement products have declined.
A-share midday | Three major indexes collectively adjusted, agriculture and digital currency surged against the trend
HK Stock Market Move | InnoCare Pharma (09969) rose over 4% as strong growth in its commercialized products coupled with business development achievements led to a turnaround in profits in the first half of the year compared to the same period last year.
HK Stock Market Move | CR BLDG MAT TEC (01313) fell nearly 3% in the morning session, with the performance for the first half of the year turning from profit to loss compared to the same period last year, and sales of cement products have declined.
A-share midday | Three major indexes collectively adjusted, agriculture and digital currency surged against the trend
HK Stock Market Move | InnoCare Pharma (09969) rose over 4% as strong growth in its commercialized products coupled with business development achievements led to a turnaround in profits in the first half of the year compared to the same period last year.
RECOMMEND
